Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


IGM Biosciences
325 East Middlefield Road
Mountain View, CA 94043
Phone: 650-965-7873
http://igmbio.com/

IGM Biosciences is a privately held biotechnology company that is focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies, and IGM believes it has the most advanced research and development program focused on engineered IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent advantages may provide superior performance, as compared to IgG antibodies.

Key Contact
NameTitleE-Mail
Fred SchwarzerCEOfred@igmbio.com


Funding Events
DateAmountTypeInvestors
07/09/19$102,000,000Series C Haldor Topsoe Holding A/S
Janus Henderson Investors
Redmile Group
Vivo Capital
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.